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Abstract
Background: In 2012, the World Health Organization (WHO) published recommendations on the use of
optimization or “task-shifting” strategies for key, effective maternal and newborn interventions (the OptimizeMNH
guidance). When making recommendations about complex health system interventions such as task-shifting,
information about the feasibility and acceptability of interventions can be as important as information about their
effectiveness. However, these issues are usually not addressed with the same rigour. This paper describes our use of
several innovative strategies to broaden the range of evidence used to develop the OptimizeMNH guidance. In this
guidance, we systematically included evidence regarding the acceptability and feasibility of relevant task-shifting
interventions, primarily using qualitative evidence syntheses and multi-country case study syntheses; we used an
approach to assess confidence in findings from qualitative evidence syntheses (the Grading of Recommendations,
Assessment, Development and Evaluation-Confidence in Evidence from Reviews of Qualitative Research (GRADE-
CERQual) approach); we used a structured evidence-to-decision framework for health systems (the DECIDE
framework) to help the guidance panel members move from the different types of evidence to recommendations.
Results: The systematic inclusion of a broader range of evidence, and the use of new guideline development tools,
had a number of impacts. Firstly, this broader range of evidence provided relevant information about the feasibility
and acceptability of interventions considered in the guidance as well as information about key implementation
considerations. However, inclusion of this evidence required more time, resources and skills. Secondly, the GRADE-
CERQual approach provided a method for indicating to panel members how much confidence they should place
in the findings from the qualitative evidence syntheses and so helped panel members to use this qualitative
evidence appropriately. Thirdly, the DECIDE framework gave us a structured format in which we could present a
large and complex body of evidence to panel members and end users. The framework also prompted the panel to
justify their recommendations, giving end users a record of how these decisions were made.
Conclusions: By expanding the range of evidence assessed in a guideline process, we increase the amount of time
and resources required. Nevertheless, the WHO has assessed the outputs of this process to be valuable and is
currently repeating the approach used in OptimizeMNH in other guidance processes.
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Background
In 2012, the World Health Organization (WHO) pub-
lished evidence-based recommendations regarding the use
of optimization or “task-shifting” strategies for key, effect-
ive maternal and newborn interventions (OptimizeMNH)
[1]. Typically, task-shifting involves training lower level
health worker cadres to deliver tasks that are normally de-
livered by higher level health worker cadres. The main
aim of this strategy is to increase access to care for people
living in areas with a shortage of health workers.
While task-shifting strategies have the potential to in-
crease access to care in settings with critical shortages of
specialised health workers, there is also concern that the
delivery of health care by health workers with less
training could cause harm to people already in vulner-
able situations. The effectiveness and safety of such in-
terventions therefore needs to be rigorously evaluated.
However, task-shifting strategies that have been assessed
as effective and safe in the context of experimental stud-
ies may be challenging to implement at scale within a
health system. The shifting of tasks from one group of
health workers to another can involve social, behavioural
and organisational change and, like other complex inter-
ventions, its success may depend not only on character-
istics of the intervention itself but also on characteristics
of the systems in which the intervention is implemented
or on interactions between properties of the intervention
and systems [2–4]. The success of task-shifting strategies
is also likely to be influenced by factors such as the
training, supervision and support provided to health
workers as well as access to supplies and referral systems.
The culture and organisation of healthcare delivery in a
particular setting, as well as views and expectations among
stakeholders such as service users, the providers involved
in task-shifting and managers, may also play important
roles in the success of these types of strategies [5–7]. Fur-
thermore, the shifting of tasks can have serious implica-
tions for health worker motivation, for instance because of
changes in working conditions and salaries, and for health
service users’ experience of care [8, 9].
As these issues can represent important challenges to
successful implementation, information about an inter-
vention’s feasibility and acceptability can therefore be as
important as information regarding intervention effect-
iveness and safety when recommendations are made.
Initiatives that aim to improve the quality of guidelines,
such as the AGREE II instrument, also emphasise the
importance of seeking stakeholders’ views and prefer-
ences, and of discussing potential organisational barriers
to the application of recommendations [10]. But despite
their potential importance, questions about acceptability
and feasibility are usually not addressed with the same
rigour as questions about intervention effectiveness. In-
stead, it appears that these issues are often left to the
opinions and experiences of guideline panel members.
While this input is useful as part of a dialogue [11], it is
limited by the composition of the group. For global guide-
lines such as OptimizeMNH, the input of panel members
from specific geographic or clinical settings and with ex-
perience of particular population groups may not give
sufficient insight into the values and experiences of ser-
vice users and other stakeholders more broadly. In
addition, the perspectives of some panel members may
take precedence over other members because of per-
ceived differences in social status within the guideline
panel [12, 13].
As the technical team responsible for developing the
OptimizeMNH guidance (Table 1), we saw a need to ad-
dress these issues in the evidence-to-decision process. In
this paper, we describe our use of innovative strategies
to expand the evidence used as a basis for WHO rec-
ommendations and discuss our experiences with these
strategies.
Methods
In developing the OptimizeMNH guidance, we followed
the standard procedures set out in the WHO’s Handbook
for Guideline Development [14]. These procedures (which
include the formulation of questions and outcomes; the
retrieval, assessment and synthesis of evidence; the devel-
opment and formulation of recommendations; and finally,
the dissemination and implementation of these recom-
mendations) are intended to ensure that WHO recom-
mendations address key needs and are evidence-based
[15]. However, we also elaborated on these standard pro-
cedures by adopting innovative approaches that could
help us address our goal of producing evidence-informed
recommendations that are informed by a broader set of
evidence than data on effectiveness alone. These ap-
proaches were used at different stages of guidance devel-
opment: when gathering the evidence to support the
guidance, when assessing and synthesising this evidence,
Table 1 Defining guidance
Guidance in the context of health systems can be defined as
“systematically developed statements produced at global or national
levels to assist decisions about appropriate options for addressing a
health systems challenge in a range of settings and to assist with
the implementation of these options and their monitoring and
evaluation” [49].
The term “guidance” can be seen as preferable to the more prescriptive
term “guidelines” as health systems, public health and other complex
interventions, and the evidence on these issues are often very context
sensitive. Health systems guidance statements (which are also
sometimes referred to as recommendations) would usually include
policy options accompanied by assessments of the quality of evidence
supporting them, including evidence of unintended consequences and
of acceptability and feasibility issues and resource use. Guidance
statements may also be accompanied by discussions of implementation
and contextual issues.
Adapted from [49]
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and when developing the recommendations (Table 2). The
approaches included the following:
– Broadening the range of evidence used in the
guidance by including systematic reviews of
qualitative research, multi-country case study syn-
theses and results from a primary qualitative study
– Using the Grading of Recommendations,
Assessment, Development and Evaluation-
Confidence in Evidence from Reviews of Qualitative
Research (GRADE-CERQual) approach to assess our
confidence in the evidence from systematic reviews
of qualitative research
– Using a structured health systems framework (the
DECIDE framework) to help the guidance panel
move from this wider range of evidence to
recommendations
Results
Gathering the evidence—broadening the range of
evidence included in the guidance
The WHO’s Handbook for Guideline Development de-
scribes not only several types of questions that can legit-
imately be addressed in a WHO guideline, including the
effectiveness or efficacy of an intervention, but also the
negative consequences of the intervention, its social ac-
ceptability and its cost-effectiveness. The Handbook de-
scribes how qualitative evidence synthesis can be used to
explore contextual barriers as well as values and prefer-
ences [14]. The main focus of the Handbook is, however,
on the use of evidence about effectiveness and, in prac-
tice, most WHO guidelines have focused almost exclu-
sively on this question.
For OptimizeMNH, we systematically assessed the ef-
fectiveness and safety of the relevant task-shifting inter-
ventions through systematic reviews and the use of
GRADE. In addition, we used an innovative approach in
this stage of guidance development by systematically in-
cluding other types of evidence. Specifically, we com-
piled evidence on the acceptability of the interventions
among health workers, recipients of care, policy makers
and other stakeholders and on the feasibility of these
interventions, taking into account the organisational
changes to health systems that each task-shifting inter-
vention would entail.
While systematic reviews of randomised trials are seen
as the most robust source of evidence when assessing
intervention effectiveness, this approach is not well-
suited for exploring issues surrounding intervention ac-
ceptability and feasibility, particularly for more complex
health and social interventions [2, 16]. To answer these
questions, we included systematic reviews of qualitative
studies (sometimes called qualitative evidence syntheses)
as our primary source of evidence [17]. Together with
colleagues, we co-authored four qualitative evidence syn-
theses focusing on factors affecting the implementation
of task-shifting among lay health workers, midwives,
doctors and nurses [18–21].
The qualitative evidence syntheses provided us with in-
formation that was clearly relevant to the questions we
had asked. However, most of the studies were of relatively
small-scale or pilot programmes, often implemented in
the context of research, and focused on factors unfolding
at the level of programme delivery in communities and
primary care facilities. We decided therefore to comple-
ment this evidence with two multi-country case study syn-
theses focusing on factors affecting the implementation of
large-scale programmes. When selecting these pro-
grammes, we aimed for broad geographical representation
and looked for countries in Africa, Asia and South Amer-
ica that had implemented large-scale programmes. To
make the synthesis manageable, we limited ourselves to
seven programmes and only selected programmes where a
reasonable amount of English-language documentation
was available. The multi-country case study syntheses
aimed to identify “upstream”, system-level factors as-
sociated with programme policies, governance, finan-
cing, planning, management and organisation [1, 22].
These case studies synthesised evidence from a variety
of sources, including peer-reviewed qualitative and quanti-
tative studies, programme reports, web sites and informa-
tion from personal communication with individuals
familiar with the selected task-shifting programmes.
Another limitation of the evidence we identified through
the qualitative evidence syntheses was that it focused pri-
marily on the views and experiences of service users and
healthcare providers but paid less attention to the view-
points of programme managers, policy makers and other
stakeholders. We attempted to address this imbalance by
carrying out our own primary study. We undertook quali-
tative analyses of the views and experiences of those con-
tributing to the “Health Information For All By 2015”
electronic discussion list, which covers a diverse member-
ship of programme managers, healthcare providers, policy
makers, academics and others from 170 countries [23].
These analyses evaluated opinions about how the roles of
healthcare providers could be optimised to improve ma-
ternal and newborn health in LMICs and the implications
of such role optimization [1, 24].
When presenting the evidence from the qualitative
evidence syntheses, the country case studies and the pri-
mary qualitative studies, we attempted to extract find-
ings that were relevant to specific recommendations
being considered by the guidance panel and that con-
cerned specific tasks and groups of health workers.
These findings were used to (a) support the guidance
panel when reaching recommendations and (b) develop
information for end users of the guidance regarding
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Table 2 Innovative strategies and resources available to guidance developers
Stage of the guidance Innovative approaches used in
the OptimizeMNH guidance
Areas of use Resources available to guideline organisations
interested in using similar approaches
Gathering the evidence Systematic reviews of qualitative
research (also referred to as
qualitative evidence syntheses)
Can be used to:
- Gather evidence about stakeholders’ views
and preferences, for instance, on which
outcomes that stakeholders value the most
in relation to the guidance question/s
- Gather evidence about the acceptability
and feasibility of interventions
- Offer information about implementation
considerations
- WHO Handbook for guideline development, chapter 15 on
using evidence from qualitative research to develop WHO guidelines:
http://www.who.int/kms/guidelines_review_committee/en/
- Developing NICE guidelines: the manual: https://www.nice.org.uk/article/
pmg20/chapter/1-Introduction-and-overview
- Website of the Cochrane Qualitative and Implementation Methods Group,
which includes guidance on conducting qualitative evidence syntheses:
http://methods.cochrane.org/qi/supplemental-handbook-guidance
- Texts on conducting qualitative evidence syntheses: [33, 35]
Multi-country case study syntheses Can be used to gather evidence about the
issues mentioned above and may be
particularly useful where reviews of
qualitative research do not cover sufficiently
macro-level issues




Evidence from Reviews of
Qualitative Research”) approach
Used to transparently assess and describe
how much confidence to place in findings
from qualitative evidence syntheses
- Website with information about the GRADE-CERQual approach:
www.cerqual.org





A structured health system framework to
help guidance panel members move from
evidence to recommendations. For each
guidance question, the framework presented,
in a structured format, a summary of the
evidence regarding:
• The benefits and harms of the intervention
• Anticipated resource use
• Acceptability of the intervention, i.e. the
extent to which that intervention is
considered to be reasonable among those
receiving, delivering or affected by the
intervention
• Feasibility of the intervention, i.e. the
likelihood that the intervention can be
properly carried out or implemented in a
given context
- Website: https://ietd.epistemonikos.org/#/login













implementation considerations for each recommenda-
tion. Tables 3 and 4 provide examples of how these find-
ings informed the development of recommendations in
the OptimizeMNH guidance.
We also wanted to offer those using the OptimizeMNH
guidance more general information about the acceptability
and feasibility of task-shifting strategies. We therefore car-
ried out a “cross-cutting” analysis of findings from all of
the sources described above. This cross-cutting analysis
provided evidence regarding task-shifting in general where
no direct evidence was available for specific task-shifting
interventions. The cross-cutting analysis also contributed
to a chapter in the WHO OptimizeMNH guidance on
overarching implementation considerations.
Assessing and synthesising the evidence—introducing an
approach to assess our confidence in findings from
qualitative evidence syntheses
The WHO Guideline Handbook notes that guideline tech-
nical teams need to provide an assessment of the quality
of the evidence included in a WHO guideline [14]. For
evidence of effectiveness, the WHO uses the GRADE ap-
proach to assess quality [25]. GRADE is not, however, de-
signed to be applied to qualitative research, and we were
not aware of other systems for assessing quality or confi-
dence in findings from qualitative evidence syntheses or
for indicating these assessments to end users. Having
made the decision to include qualitative evidence synthe-
ses, we therefore needed an approach in transparently
assessing and describing how much confidence to place in
findings from these types of syntheses.
Work to develop this approach was carried out in col-
laboration with other qualitative researchers [26], in-
formed by the principles of qualitative research. We were
also influenced by the processes used by the GRADE
Working Group, which has given considerable thought to
how to assess confidence in evidence from systematic re-
views. This work resulted in an approach which we named
Table 3 Example of how the qualitative evidence informed the
final recommendations in the OptimizeMNH guidance (1):
provision of continuous support during labour by lay health
workers, in the presence of a skilled birth attendant
The guidance panel was asked to consider whether lay health workers
could provide continuous support, such as emotional and practical
support, during labour, while in the presence of a skilled birth attendant
providing the necessary clinical care.
Information regarding benefits and harms came from a systematic review
of trials [51]. This evidence suggested that this support, when provided by
lay health workers or other birth supporters, may have important health
benefits (low to moderate certainty evidence). Based on discussion in the
technical team, we also concluded that the intervention would require
little additional training, supervision and supplies.
Information regarding acceptability and feasibility came from two
syntheses of qualitative evidence [19, 20]. The evidence suggested that
mothers appreciated this support from lay health workers and that
health professionals working alongside lay health workers often
appreciated their contribution to their busy workload and their skills in
communicating with mothers (moderate confidence in the evidence).
However, the relationships between lay health workers or other birth
supporters and professional midwives was sometimes ambivalent and,
at times, conflictual, possibly because the midwife role was shifted in a
more medical direction (moderate confidence in the evidence). Having
to be present during labour and birth could also lead to irregular and
unpredictable working conditions for the lay health worker, which
might have implications for their expectations regarding incentives (low
confidence in the evidence) and could lead to concerns about personal
safety when working in the community or travelling at night (low
confidence in the evidence).
This information was presented to the guidance panel in a summarised
form using the DECIDE evidence to decision framework. More detailed
versions were presented in appendices using summary of findings tables
and full versions of each review were also made available to the panel.
Based on this evidence, the panel decided to recommend the
intervention. Potential challenges regarding the acceptability of the
intervention to lay health workers and other healthcare providers were
highlighted under “Implementation considerations”.
Adapted from [1]
Table 4 Example of how the qualitative evidence informed the
final recommendations in the OptimizeMNH guidance (2):
provision of vasectomy by trained midwives
The guidance panel was asked to consider whether midwives could
perform vasectomies.
We were unable to identify any eligible studies that assessed the
benefits or harms of midwives performing vasectomies. We did have
indirect evidence from one systematic review of trials [52] that there
may be little or no difference between midwives and doctors with
regard to complications during surgery or postoperative morbidity for
tubal ligation (low quality evidence).
Based on discussion in the technical team, we concluded that the
intervention would require additional training, supervision and supplies
and a functioning referral system for failed vasectomies or complications
and might also require changes to norms and regulations.
Information regarding acceptability and feasibility came from one
synthesis of qualitative evidence [20]. The synthesis did not identify any
studies that evaluated the acceptability of vasectomy when performed by
midwives. For other midwife-delivered interventions, the synthesis
suggested that midwives and their trainers generally felt that
midwives had no problem learning new clinical techniques (moderate
confidence in the evidence) and might be motivated by being “upskilled”
as this could lead to increased status, promotion opportunities and
increased job satisfaction (moderate confidence in the evidence).
However, midwives might be unwilling to take on tasks that moved
beyond obstetric care, such as tasks related to family planning, possibly
because this was not viewed as part of their role and might entail an
increased workload (moderate confidence in the evidence). In addition, a
lack of clarity in roles and responsibilities between midwives and other
healthcare providers, as well as status and power differences, might also
lead to poor working relationships and “turf battles” (moderate confidence
in the evidence). Finally, the synthesis suggested that additional training
and supervision were often insufficient in midwife task-shifting
programmes.
This information was presented to the guidance panel in a summarised
form using the DECIDE framework. More detailed versions were
presented in appendices using summary of findings tables and full
versions of each review were also made available to the panel.
Based on this evidence, the panel decided to recommend the
intervention only in the context of rigorous research. The panel further
specified that implementation in the context of research should only be
done where a well-functioning midwife programme already exists and a
well-functioning referral system is in place or can be put in place.
Adapted from [1]
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GRADE-CERQual [26]. Since its initial use in the Optimi-
zeMNH guidance, CERQual is being developed further as
part of the GRADE Working Group and is now being
used in several other WHO guidance development pro-
cesses [27].
Developing the recommendations: using a structured
health systems framework
When assessing the different factors that influence rec-
ommendations, including effectiveness, acceptability,
feasibility, and cost, the Guideline Handbook [14] sug-
gests that the guideline panel makes use of evidence-to-
recommendation tables. These tables can be used to lay
out what we know about these different factors and can
also be used to record the guideline panel’s judgements
about these factors and how they contributed to the de-
velopment of the recommendation [14]. For Optimi-
zeMNH, we piloted an early paper version of a decision
table developed by the DECIDE project [28] and the
Grade Working Group [29]: the DECIDE Evidence to
Decision framework [30, 31].
The DECIDE framework aims to help guidance panel
members move from evidence to health system recom-
mendations by informing judgements about the balance
of consequences of each option. The framework is based
on a review of relevant literature, brainstorming, feed-
back from stakeholders [32], and the application of the
framework to examples.
For each guidance question, the framework presented,
in a structured format, a summary of the evidence re-
garding the following considerations:
 The benefits and harms of the intervention/s
(sometimes referred to as “effectiveness and safety”)
 Anticipated resource use
 Acceptability of the intervention/s
 Feasibility of the intervention/s
For each of these elements, the framework also in-
cluded an assessment of the certainty of the evidence,
using GRADE (for evidence of effectiveness) and CERQ-
ual (for evidence on acceptability and feasibility from
qualitative evidence syntheses). The following were also
included for each guidance question:
 A judgement regarding the balance of desirable and
undesirable consequences for the intervention/s
 A recommendation and a justification for this
 Implementation considerations for the intervention/s
 Relevant monitoring and evaluation/research
priorities in relation to the intervention/s
In addition to the evidence collated in the DECIDE
frameworks, full evidence profiles for the reviews of the
effectiveness of interventions, as well as summaries of
findings for the qualitative evidence syntheses on the ac-
ceptability, feasibility and implementation of these inter-
ventions, were made available to the guidance panel.
These summaries were, in turn, linked to full systematic
reviews. The DECIDE Team also prepared a video to
help guidance panel members understand the purpose of
the framework and how to use it. This was made avail-
able prior to the guidance panel meeting and also shown
at the start of the meeting.
Discussion
Broadening the range of evidence included in guidance:
lessons learnt
The first innovative approach that we used in the devel-
opment of the OptimizeMNH guidance was the system-
atic inclusion of additional types of evidence to
complement the evidence of effectiveness (Table 5). This
approach had a number of implications. On a practical
level, broadening the scope of evidence to be considered
in relation to each guidance question required more
time and resources. It also required a wider set of syn-
thesis, assessment and interpretation skills within the
technical team preparing the documents for the guid-
ance panel. In our case, these skills were represented
within the technical team. Other technical teams using a
similar guidance development approach may not have
the skills to undertake qualitative evidence syntheses or
country case study syntheses but will at least need skills
in commissioning and critically appraising such evi-
dence. Creating technical teams with these skills may be
challenging as there are few groups with extensive ex-
perience in implementing them. However, the number
of researchers with the appropriate skills is increasing
rapidly, and guidance is now well-developed [33–35].
We had originally planned to gather evidence about
stakeholder acceptability and feasibility through qualita-
tive evidence syntheses only. As described above, these
syntheses, which only included published qualitative
studies, primarily offered evidence surrounding factors
and stakeholders at the community or primary health-
care facility level. This led us to carry out the multi-
country case studies, where we included a broader set of
information sources, and also led us to carry out our
own primary study among stakeholders poorly repre-
sented in the qualitative evidence syntheses. In retrospect,
we think that the findings of this primary study should
have been included in the qualitative evidence syntheses
rather than being treated as a stand-alone product.
Although this innovation expanded the preparatory
work needed for the guidance, we would argue that the
inclusion of evidence from qualitative evidence syntheses
and country case study syntheses offered relevant infor-
mation for the guidance panel on the feasibility and
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acceptability of the interventions. When such evidence is
not systematically assessed and included, acceptability
and feasibility issues may either be overlooked altogether
or incorporated into guideline decisions based only on
anecdotal evidence. Our experience from the develop-
ment of the OptimizeMNH guidance suggests that the
inclusion of evidence from qualitative evidence syntheses
and country case study syntheses reduced the use of an-
ecdotal evidence by guidance panel members when
assessing the balance of consequences for each guidance
question. In addition, our use of such evidence appeared
to address guideline panel members’ perceptions that
the WHO often over-emphasises evidence from rando-
mised trials at the expense of evidence from programme
experience. One additional benefit of synthesising rele-
vant qualitative evidence was that we were able to use
this to develop implementation considerations for task-
shifting in maternal and newborn health [1].
Introducing an approach to assess confidence in findings
from qualitative evidence syntheses: lessons learnt
Our second innovation was the use of the GRADE-
CERQual approach in order to systematically and transpar-
ently assess our confidence in findings from the qualitative
evidence syntheses conducted to inform the guidance.
Our use of CERQual was received well by the guidance
panel, in part because it addressed the need to systemat-
ically incorporate a wider range of evidence into the
guidance process. The approach also had a number of
advantages. When making recommendations, all guid-
ance panels need to take into account how confident
they can be in the underlying evidence. Had we not pro-
vided the OptimizeMNH panels with the CERQual as-
sessments of our confidence in the findings from the
qualitative evidence syntheses, they would have had to
make their own judgments and may not have done this
in a systematic way. The use of CERQual also allowed us
to identify and highlight gaps in the evidence. For in-
stance, where we assessed the confidence in the evidence
for a qualitative finding to be low or very low, this was
an indication that further research was needed in this
area. These research gaps were also reflected in the in-
formation presented to the guidance panel and carried
through to the recommendations.
We were initially concerned that using the CERQual
approach would confuse guidance panel members as
they would not have encountered this approach before.
In practice, this did not appear to be a problem, prob-
ably because members were already familiar with
GRADE for assessing findings regarding the effective-
ness of interventions, which uses the same principles,
and because the panel was briefed on the approach at
the start of the meetings.
Some of the findings contributing to OptimizeMNH
were based on a very wide range of evidence types. In par-
ticular, the country case studies included both qualitative
and quantitative studies as well as programme reports,
which often did not provide detailed descriptions of
methods used. Using CERQual to assess our confidence in
the findings from the country case study syntheses was
not feasible as the CERQual approach is not designed, at
present, to accommodate this range of evidence [26].
Using a structured health systems framework: lessons
learnt
Our final innovation was the use of DECIDE evidence-
to-decision frameworks [36] to present evidence to the
guidance panel. There were several advantages in using
Table 5 Overview of the different types of evidence used in the OptimizeMNH guidance development process
What type of evidence did we use? Which part of the DECIDE evidence-to-decision
framework was it used to address?
What type of evidence did it consider?
Systematic reviews of effectiveness - What are the benefits and harms of the different
task-shifting options?
The reviews primarily included randomised trials of
task-shifting interventions. In some reviews,
non-randomised study designs were also included.
Qualitative evidence syntheses - Is the task-shifting option acceptable to most
stakeholders?
- Is the task-shifting option feasible to implement?
The qualitative evidence syntheses included primary
studies of task-shifting that had used qualitative methods
for data collection and for data analysis
Multi-country case study syntheses - Is the task-shifting option acceptable to most
stakeholders?
- Is the task-shifting option feasible to implement?
The multi-country case study syntheses reviewed
evaluations and studies of large-scale programmes
designed to optimise the health workforce in LMICs.
Evaluation reports, programme guidelines and published
studies were gathered for each selected country
programme
Primary research - Is the task-shifting option acceptable to most
stakeholders?
- Is the task-shifting option feasible to implement?
The primary research involved qualitative thematic
analysis of messages submitted to two email discussion
forums.
The forums focus on the healthcare information needs
of frontline health workers and citizens in LMICs and
how these needs can be met and also include discussion
of diverse aspects of health systems.
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this structured framework. Firstly, the framework helped
panel members to think through each of the consider-
ations that might be important in making a recommen-
dation and ensured that key considerations were taken
into account. The concise format also appeared to help
focus and structure the discussions and may have im-
proved the use of the limited time that the guidance
panel had to weigh the balance of consequences and
make judgements about complex questions regarding
task-shifting. Because the framework prompted the guid-
ance panel to justify all of the recommendations made,
we believe that the transparency of the decision-making
process was improved. Furthermore, end users of the
guidance have access to a clear record of recommendation
decisions and how these were made. The framework also
contributes to closing the knowledge-to-action cycle by
capturing implementation considerations and highlighting
evidence gaps where more research is needed [37, 38].
The use of the evidence-to-decision frameworks also
led to a number of challenges. First of all, preparation of
the frameworks took considerable time in advance of the
panel meeting, although this may have saved time later
on when preparing the final guidance document. Sec-
ondly, because the DECIDE framework is a new tool, it
required some explanation in advance of the panel meet-
ings. However, panel members appeared to grasp the
function and content quickly, and the informal feedback
on the framework was positive.
Because the OptimizeMNH guidance included a very
large number of recommendations (128 in total), the
amount of time available in the panel meetings to dis-
cuss each evidence-to-decision framework was limited.
The inclusion of additional types of evidence also added
to the amount of information that panel members were
expected to read. Nonetheless, our experience suggests
that the structured format of the DECIDE framework
allowed the technical team to present a large and com-
plex body of evidence to panel members in a fairly
straightforward and easy-to-assimilate way. Further
work is now needed to explore guidance panels’ views
of such evidence-to-decision frameworks and to exam-
ine how the presentation of evidence in these formats
impacts on the deliberations and decisions of guidance
panels and on the transparency to users of these
decisions.
Conclusion
In this paper, we have described our use of a number of
innovative strategies to expand the range of evidence
used to develop WHO global recommendations and dis-
cussed our experiences with these strategies. Expanding
the range of evidence contributing to a guidance process
increases the amount of time and resources needed and
the range of skills required within the technical team
Table 6 When to consider expanding the range of evidence
syntheses undertaken to inform the development of a guideline
or guidance
Principles:
• For most interventions for which guidance is developed, including
clinical, health systems and public health interventions, guidance
panels should consider how different stakeholders value different
outcomes; the effectiveness, acceptability and feasibility of the
intervention; implications for resource use; equity impacts; and
implementation considerations
• A structured evidence-to-decision framework, such as the DECIDE
framework [30, 31], should be used to guide these considerations, even
if it is likely that evidence syntheses will not be needed for some of
the considerations included in these frameworks (see below)
When to consider expanding the range of evidence syntheses informing
guidance development:
• Expanding the range of evidence syntheses beyond evidence of
effectiveness should be considered under the following circumstances:
◦ If the guidance is considering a new intervention, an intervention
for which guidance has not previously been developed, or an
intervention for which the implementation mechanism/s have
changed
◦ If there are reasons to anticipate that feasibility, acceptability,
resource use and/or equity are likely to be important considerations
for the interventions included in this guidance. These considerations
may be particularly important for interventions directed at health
systems or other systems; interventions that focus on changing
people’s views or behaviours; and interventions that have multiple
components and long causal pathways or involve multiple actors or
systems. Note that stakeholders should be involved in discussions
on this issue
• If a decision has been made that the range of evidence syntheses
needed to support the development of guidance should be expanded,
consider the following:
◦ Do evidence syntheses already exist that could be used to address
the considerations identified?
◦ Will existing evidence syntheses require additional work, for
example, to assess how much confidence to place in the synthesis
findings and/or to undertake specific subgroup analyses?
◦ If existing evidence syntheses are not available for some or all of
the considerations to be explored by the guidance:
▪ Do the timeline and resources available for the guidance
development allow for new syntheses to be undertaken?
▪ If so, which are the highest priority considerations for new
syntheses and what should be the scope of these syntheses?
▪ What skills are likely to be required to undertake these syntheses?
Are the skills to undertake these syntheses available within the
lead organisation for the guidance or do they need to be
commissioned externally?
▪ What financial and other resources are needed to conduct these
syntheses within the timeframe for development of the
guidance?
▪ Could the process of conducting multiple evidence syntheses be
made more efficient by combining database searching and
screening for several of the syntheses, such as those syntheses
focusing on intervention effectiveness, acceptability, feasibility
and resource use considerations?
• Once the evidence syntheses are underway or available, consider the
following:
◦ What tools are needed to assess how much confidence to place in
the synthesis findings (for instance, the GRADE approach)? Will
these assessments be conducted by the review teams, by the
guidance commissioners or by a third party?
Who will be responsible for summarising the available evidence in
order to populate an evidence-to-decision framework for each
guidance question?
Glenton et al. Implementation Science  (2016) 11:98 Page 8 of 11
developing the guidance. However, our experience with
the OptimizeMNH guidance suggests that such efforts
may be valuable, particularly for recommendations on
more complex health and social interventions. This view
is supported by efforts within WHO to replicate the
OptimizeMNH approach in other guidance processes
[27]. When considering whether to adopt a similar ap-
proach, producers of guidance should assess the extent
to which acceptability and feasibility issues are likely to
be important enough to influence their recommenda-
tions. So far, the WHO is using this approach in recom-
mendations in guidance on more complex health
systems and behavioural interventions, but acceptability
and feasibility issues may be equally relevant for clinical
interventions. In fact, we would suggest that there are
few situations where these issues are not likely to be
relevant, and even in situations where guidance devel-
opers feel confident that they already have a sufficient
overview of these issues and additional evidence is not
required, a framework approach where this is made
transparent can still be useful. We have developed a list
of questions (Table 6) to help groups involved in devel-
oping guidance decide whether additional evidence syn-
theses are needed. Further research is needed to refine
these questions and to develop an understanding of the
typical time and resources required to expand the range of
evidence sources used to develop guidance. Table 2 also
provides links to resources available to guidance devel-
opers who are considering expanding the range of synthe-
ses that will be used to inform the guidance.
As more qualitative evidence syntheses are produced,
methods for synthesising this type of evidence are becom-
ing more sophisticated and the number of people able to
produce these types of syntheses is growing. These devel-
opments will make the process of including qualitative
evidence in evidence-to-decision processes easier in the
future. However, a number of challenges remain, as dis-
cussed above. Elsewhere, we have described how evidence
from qualitative research can be used in developing guide-
lines [39], including to help shape a guideline’s key
questions by informing the populations, interventions,
comparators and outcomes on which each key question
should focus and to understand how different stake-
holders value different outcomes. We did not use these
additional strategies in OptimizeMNH, but they have been
part of the development for a forthcoming WHO guide-
line on antenatal care [40].
Our experience from OptimizeMNH suggests that rele-
vant programmatic experience regarding “upstream”
systems-level factors is often unexplored or undocumented
using traditional research approaches. Researchers should
explore these issues to a greater extent [22]. Alongside this,
we need to develop better methods for identifying and syn-
thesising information from programme reports and other
grey literature as well as methods for assessing our confi-
dence in syntheses based on this type of data [41, 42].
The OptimizeMNH experience suggests that the DE-
CIDE evidence-to-decision frameworks are a useful way
of guiding panels through a wide range of evidence and
towards the development of transparent recommenda-
tions. We have learnt a great deal about how to populate
these frameworks with evidence of the effectiveness,
feasibility and acceptability of health interventions. How-
ever, more research is needed, in particular on how these
kinds of evidence are used by guidance panels in their
decision-making and how different kinds of evidence in-
fluence the final recommendations made. In addition,
we need further worked examples of approaches for in-
cluding evidence regarding resource use and cost-
effectiveness. This is one area that those involved in the
DECIDE work are exploring [36].
Finally, we need to explore how this type of health sys-
tem guidance can best be disseminated to and utilised by
end users, including national and regional policy makers
and programme planners. For most health systems ques-
tions, evidence regarding effectiveness, acceptability, feasi-
bility, and resource use is all likely to be context-specific
to some degree. End users therefore need help in adapting
the recommendations to their own contexts. The Optimi-
zeMNH guidance includes a workbook that specifically
aims to help end users contextualise the recommenda-
tions [43]. However, more work is needed on tools to con-
textualise global and national research and guidance for
implementation in specific settings [44–47] and on ways
of appraising such guidance [48].
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